While the classical cell-based screening method has been successfully used in drug discovery process, it is an expensive, time-consuming and labor-intensive approach. Recent advances in application of computation methods in genome, proteome, and metabolome mining coupled with complete genome sequences of pathogen organisms have opened an alternative path toward identifying new drug targets. For instance, several reports have confirmed the usefulness of comparative genome analysis in identification of pathogen-specific drug and vaccine candidates.